COVID-19-Related Mortality amongst Physicians in Italy: Trend Pre- and Post-SARS-CoV-2 Vaccination Campaign

Alberto Modenese1, Tom Loney2, Fabriziomaria Gobba1

  • 1Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Insights

COVID-19 vaccination campaigns significantly reduced mortality among Italian physicians. Mortality rates in March-May 2021 were 12 times lower than in March-May 2020, demonstrating vaccine effectiveness in protecting healthcare workers.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Healthcare workers faced high COVID-19 mortality globally during the SARS-CoV-2 pandemic.
  • Anti-COVID-19 vaccination campaigns aimed to protect frontline workers and decrease occupational mortality.

Purpose of the Study:

  • To analyze COVID-19-related mortality data for physicians in Italy.
  • To compare mortality rates before and after the widespread implementation of COVID-19 vaccination.

Main Methods:

  • Comparative analysis of crude COVID-19 mortality rates among Italian doctors.
  • Data comparison between March-May 2020 (pre-vaccination) and March-May 2021 (high vaccination coverage).
  • Correlation analysis between vaccine doses administered and mortality trends.

Main Results:

  • Physician COVID-19 mortality was 12 times higher in March-May 2020 compared to March-May 2021.
  • A strong inverse correlation was observed between cumulative vaccine doses and mortality.
  • Recent trends (Sept-Oct 2021) suggest the need for a third vaccine dose.

Conclusions:

  • The COVID-19 vaccination campaign was effective in protecting Italian physicians and reducing SARS-CoV-2-related mortality.
  • Vaccine effectiveness is supported by the significant decrease in mortality post-vaccination.
  • Data indicates the ongoing importance of booster doses for sustained protection.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
585
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
319
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
765
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
128
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14